Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Patrick J. Hensley"'
Autor:
Patrick J. Hensley, Niyati Lobo, Kelly K. Bree, Wei Shen Tan, Paolo Gontero, Stephen B. Williams, Charles C. Guo, Gianluca Giannarini, Lars Dyrskjøt, Ashish M. Kamat
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 4, Pp 245-257 (2022)
Bladder cancer (BC) is a heterogeneous disease with prognosis and therapeutic strategies highly dependent on tumor grade and stage. Predictive biomarkers of therapeutic response have been studied to guide selection of intravesical and/or systemic the
Externí odkaz:
https://doaj.org/article/45c870cc8b674bab86881034b1a5cd23
Autor:
Zin W. Myint, Zena Chahine, Rani Jayswal, Emily Bachert, Robert J. McDonald, Stephen E. Strup, Andrew C. James, Patrick J. Hensley, Derek B. Allison
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 6, p 885 (2023)
Objective: CD47 is an antiphagocytic molecule that plays a critical role in immune surveillance. A variety of malignancies have been shown to evade the immune system by increasing the expression of CD47 on the cell surface. As a result, anti-CD47 the
Externí odkaz:
https://doaj.org/article/2091118ebbd2482980af7db47a5aa19f
Autor:
Zin W. Myint, William H. St. Clair, Stephen E. Strup, Donglin Yan, Ning Li, Derek B. Allison, Laurie E. McLouth, Carleton S. Ellis, Peng Wang, Andrew C. James, Patrick J. Hensley, Danielle E. Otto, Susanne M. Arnold, Robert S. DiPaola, Jill M. Kolesar
Publikováno v:
Cancers, Vol 15, Iss 9, p 2505 (2023)
Purpose: Cannabinoids (CBD) have anti-tumor activity against prostate cancer (PCa). Preclinical studies have demonstrated a significant decrease in prostate specific antigen (PSA) protein expression and reduced tumor growth in xenografts of LNCaP and
Externí odkaz:
https://doaj.org/article/8250b59136044aa5a004026ee8f46761
Publikováno v:
Asian Journal of Urology, Vol 6, Iss 1, Pp 82-90 (2019)
The long-standing challenge in the treatment of prostate cancer is to overcome therapeutic resistance during progression to lethal disease. Aberrant transforming-growth factor-β (TGF-β) signaling accelerates prostate tumor progression in a transgen
Externí odkaz:
https://doaj.org/article/01e0280a687d45e0adbc732213dbefcb
Autor:
Zin W. Myint, Ramon C. Sun, Patrick J. Hensley, Andrew C. James, Peng Wang, Stephen E. Strup, Robert J. McDonald, Donglin Yan, William H. St. Clair, Derek B. Allison
Publikováno v:
Cancers, Vol 13, Iss 9, p 2157 (2021)
High Glutaminase (GLS1) expression may have prognostic implications in colorectal and breast cancers; however, high quality data for expression in prostate cancer (PCa) are lacking. The purpose of this study is to investigate the status of GLS1 expre
Externí odkaz:
https://doaj.org/article/8091525d917a408392b7350060ebfe42
Autor:
Patrick J. Hensley, Valeria Panebianco, Eugene Pietzak, Alexander Kutikov, Raghu Vikram, Matthew D. Galsky, Shahrokh F. Shariat, Morgan Roupret, Ashish M. Kamat
Publikováno v:
European Urology Oncology. 5:403-411
Bladder cancer prognosis and treatment are heavily dependent on accurate staging. Traditional imaging and pathologic evaluation of transurethral resection (TUR) specimens have been associated with high rates of clinical understaging at the time of ra
Autor:
Kelly K. Bree, Patrick J. Hensley, Niyati Lobo, Nathan A. Brooks, Graciela M. Nogueras-Gonzalez, Charles C. Guo, Neema Navai, H. Barton Grossman, Colin P. Dinney, Ashish M. Kamat
Publikováno v:
Journal of Urology. 208:284-291
Autor:
Kelly K. Bree, Andrea Kokorovic, Mary E. Westerman, Patrick J. Hensley, Nathan A. Brooks, Wei Qiao, Yu Shen, Ashish M. Kamat, Colin P. Dinney, Neema Navai
Publikováno v:
Journal of Urology.
Autor:
Colin P.N. Dinney, Neema Navai, Ashish M. Kamat, Patrick J. Hensley, Justin T. Matulay, Nathan A. Brooks, Graciela M. Nogueras-Gonzalez, Kelly K. Bree, Supriya Nagaraju, H. Barton Grossman, Roger Li
Publikováno v:
Eur Urol Oncol
Background Guideline indications for restaging transurethral resection (reTUR) for high-grade (HG) Ta bladder tumors vary due to a paucity of data. Objective To investigate guideline-based, risk-adapted approaches to reTUR for HG Ta lesions. Design,
Autor:
Niyati Lobo, Patrick J. Hensley, Kelly K. Bree, Graciela M. Nogueras-Gonzalez, Neema Navai, Colin P. Dinney, Richard J. Sylvester, Ashish M. Kamat
Publikováno v:
European Urology Oncology. 5:84-91
The 2021 European Association of Urology (EAU) guidelines contain updated prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC). These groups are based on the following predictors of progression: tumour stage, grade, number, an